We were very pleased with our choice to engage innoVitro’s contractility service. The studies using human iPSC-derived cardiomyocytes were tailored to our needs to provide results comparable to already existing (in house) data and the fast execution followed by a comprehensive study report completed the service perfectly.
News
- September 14 – 17, 2020Meet us virtually at the Safety Pharmacology Society Annual Meeting this year![…]
- September 08 – 11, 2020Meet us virtually at the Advanced Therapies Congress & Expo this year![…]
- FLEXcyte Grant Winners 2020The winners of the 2020 FLEXcyte Grant were finally announced![…]
- Post date August 20, 2020